Traitement en cours...
COMPANYPRODUCTS & SERVICESPARTNERSHIPSPRESS & EVENTSCONTACT
News & PressPublicationsAgendas
201220112010200820072006200520042003200220012000199919981997199619951994199319921991
Publications

1992


Poupon MF. Metastases and drug-resistance as markers of cancer cell evolution. AIDS Research & Human Retroviruses. 8:796-806, 1992.

Thomas F. Arvelo F. Antoine E. Jacrot M. Poupon MF. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression. Cancer Research. 52:4872-7, 1992.

Cuvier C. Roblot-Treupel L. Millot JM. Lizard G. Chevillard S. Manfait M. Couvreur P. Poupon MF. Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. Biochemical Pharmacology. 44 :509-17, 1992.

Poupon MF. How do cancers resist to chemotherapy?. Pathologie Biologie. 40:923-7, 1992.

F.Thomas, F.Arvelo, E.Antoine, J.P.Moreau & M.F.Poupon. Antitumoral activity of Gastro-releasing peptide analogues on Small Cell Lung Cancer Xenografts. Contrib. Oncol. Basel Karger vol 42, pp 377-384, 1992.

F.Arvelo, T.Le Chevalier, R.Arriagada, M.Jacrot, C.Brambilla & M.F.Poupon. Expression of oncogenes, multidrug resistance and growth associated genes in small cell lung cancer implanted into nude mice. Contrib. Oncol. Basel Karger vol 42, pp 265-267, 1992.

April 22-25, 2013 | Chicago, IL | BIO International Convention
to know more
April 6-10, 2013 | Washington, DC | Annual AACR meeting
to know more
XenTech Acknowledged in Deloitte’s 2012 Technology Fast 500™ EMEA for 2nd Year Running
to know more
March 14-15, 2013 I Bologna, Italy I Stefano Cairo will be attending the SIOPEL group Spring Meeting
to know more
March 9th 2013 I Barcelona I Olivier Déas is giving a lecture at the CONPO symposium
to know more
March 7-9, 2013 | Barcelona, Spain | CONPO symposium
Breast, Colon, lung and Melanoma
to know more
Design by Ineiaki | Sitemap | Terms of use